메뉴 건너뛰기
Journal of Clinical Oncology
Volumn 33, Issue 11, 2015, Pages 1301-1302
National guidelines and level of evidence: Comments on some of the new recommendations in the american society of clinical oncology and the college of american pathologists human epidermal growth factor receptor 2 guidelines for breast cancer
Author keywords

[No Author keywords available]
Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR 2; TRASTUZUMAB; TUMOR MARKER;
EID: 84927137315     PISSN: 0732183X     EISSN: 15277755     Source Type: Journal    
DOI: 10.1200/JCO.2014.59.7211     Document Type: Letter
Times cited : (33)
References (10)
  • 1
    • 33847147313 scopus 로고    scopus 로고
    • American society of clinical oncology/college of american pathologists guideline recommendations for human epidermal growth factor receptor 2 testing in breast cancer
    • Wolff AC, Hammond ME, Schwartz JN, et al: American Society of Clinical Oncology/College of American Pathologists guideline recommendations for human epidermal growth factor receptor 2 testing in breast cancer. J Clin Oncol 25:118-145, 2007
    • (2007) J Clin Oncol , vol.25 , pp. 118-145
    • Wolff, A.C.1    Hammond, M.E.2    Schwartz, J.N.3
  • 2
    • 84890254448 scopus 로고    scopus 로고
    • Recommendations for human epidermal growth factor receptor 2 testing in breast cancer: American Society of Clinical Oncology/College of American Pathologists clinical practice guideline update
    • Wolff AC, Hammond ME, Hicks DG, et al: Recommendations for human epidermal growth factor receptor 2 testing in breast cancer: American Society of Clinical Oncology/College of American Pathologists clinical practice guideline update. J Clin Oncol 31:3997-4013, 2013
    • (2013) J Clin Oncol , vol.31 , pp. 3997-4013
    • Wolff, A.C.1    Hammond, M.E.2    Hicks, D.G.3
  • 3
    • 70849114499 scopus 로고    scopus 로고
    • Discordance between core needle biopsy (CNB) and excisional biopsy (EB) for estrogen receptor (ER), progesterone receptor (PgR) and HER2 status in early breast cancer (EBC)
    • Arnedos M, Nerurkar A, Osin P, et al: Discordance between core needle biopsy (CNB) and excisional biopsy (EB) for estrogen receptor (ER), progesterone receptor (PgR) and HER2 status in early breast cancer (EBC). Ann Oncol 20:1948-1952, 2009
    • (2009) Ann Oncol , vol.20 , pp. 1948-1952
    • Arnedos, M.1    Nerurkar, A.2    Osin, P.3
  • 4
    • 84868209856 scopus 로고    scopus 로고
    • Accuracy of estrogen receptor, progesterone receptor, and HER2 status between core needle and open excision biopsy in breast cancer: A meta-analysis
    • Chen X, Yuan Y, Gu Z, et al: Accuracy of estrogen receptor, progesterone receptor, and HER2 status between core needle and open excision biopsy in breast cancer: A meta-analysis. Breast Cancer Res Treat 134:957-967, 2012
    • (2012) Breast Cancer Res Treat , vol.134 , pp. 957-967
    • Chen, X.1    Yuan, Y.2    Gu, Z.3
  • 5
    • 33746298407 scopus 로고    scopus 로고
    • Do the histologic features and results of breast cancer biomarker studies differ between core biopsy and surgical excision specimens?
    • Burge CN, Chang HR, Apple SK: Do the histologic features and results of breast cancer biomarker studies differ between core biopsy and surgical excision specimens? Breast 15:167-172, 2006
    • (2006) Breast , vol.15 , pp. 167-172
    • Burge, C.N.1    Chang, H.R.2    Apple, S.K.3
  • 6
    • 84860282373 scopus 로고    scopus 로고
    • Concordance of HER2 status assessed on needle core biopsy and surgical specimens of invasive carcinoma of the breast
    • Lee AH, Key HP, Bell JA, et al: Concordance of HER2 status assessed on needle core biopsy and surgical specimens of invasive carcinoma of the breast. Histopathology 60:880-884, 2012
    • (2012) Histopathology , vol.60 , pp. 880-884
    • Lee, A.H.1    Key, H.P.2    Bell, J.A.3
  • 7
    • 77954735321 scopus 로고    scopus 로고
    • Reliability of human epidermal growth factor receptor 2 immunohistochemistry in breast core needle biopsies
    • Lebeau A, Turzynski A, Braun S, et al: Reliability of human epidermal growth factor receptor 2 immunohistochemistry in breast core needle biopsies. J Clin Oncol 28:3264-3270, 2010
    • (2010) J Clin Oncol , vol.28 , pp. 3264-3270
    • Lebeau, A.1    Turzynski, A.2    Braun, S.3
  • 8
    • 77950270960 scopus 로고    scopus 로고
    • Accurately assessing her-2/neu status in needle core biopsies of breast cancer patients in the era of neoadjuvant therapy: Emerging questions and considerations addressed
    • D'Alfonso T, Liu YF, Monni S, et al: Accurately assessing her-2/neu status in needle core biopsies of breast cancer patients in the era of neoadjuvant therapy: Emerging questions and considerations addressed. Am J Surg Pathol 34:575-581, 2010
    • (2010) Am J Surg Pathol , vol.34 , pp. 575-581
    • D'Alfonso, T.1    Liu, Y.F.2    Monni, S.3
  • 9
    • 84893656079 scopus 로고    scopus 로고
    • HER2 testing for breast carcinoma: Recommendations for rapid diagnostic pathways in clinical practice
    • Shaaban AM, Purdie CA, Bartlett JM, et al: HER2 testing for breast carcinoma: Recommendations for rapid diagnostic pathways in clinical practice. J Clin Pathol 67:161-167, 2014
    • (2014) J Clin Pathol , vol.67 , pp. 161-167
    • Shaaban, A.M.1    Purdie, C.A.2    Bartlett, J.M.3
  • 10
    • 69549118443 scopus 로고    scopus 로고
    • Comparison of fluorescent in situ hybridization HER-2/neu results on core needle biopsy and excisional biopsy in primary breast cancer
    • Apple SK, Lowe AC, Rao PN, et al: Comparison of fluorescent in situ hybridization HER-2/neu results on core needle biopsy and excisional biopsy in primary breast cancer. Mod Pathol 22:1151-1159, 2009
    • (2009) Mod Pathol , vol.22 , pp. 1151-1159
    • Apple, S.K.1    Lowe, A.C.2    Rao, P.N.3

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.